{"id":47683,"date":"2017-10-05T10:46:41","date_gmt":"2017-10-05T14:46:41","guid":{"rendered":"https:\/\/asweetlife.org\/?p=47683"},"modified":"2019-04-11T04:13:12","modified_gmt":"2019-04-11T08:13:12","slug":"animas-to-discontinue-manufacturing-and-sale-of-insulin-pumps","status":"publish","type":"post","link":"https:\/\/asweetlife.org\/?p=47683","title":{"rendered":"Animas to Discontinue Manufacturing and Sale of Insulin Pumps"},"content":{"rendered":"
\n

Animas Corporation has announced that it will discontinue the manufacturing and sale of Animas\u00ae Vibe\u00ae and OneTouch Ping\u00ae insulin pumps, close operations and exit the insulin pump business.<\/p>\n

Animas has selected Medtronic as its partner-of-choice to facilitate a seamless transition for patients, caregivers and healthcare providers. Patients using an Animas insulin pump will be offered the option to transfer to a Medtronic pump.<\/p>\n

Patient safety and continuity of care is of utmost importance and Animas will continue to provide customer service, training and warranty support, including providing pump supplies that are used in conjunction with the Animas\u00ae Vibe\u00ae and OneTouch Ping\u00ae insulin pumps, through a transition period.<\/p>\n

\u201cWe recognize that patients living with diabetes rely on our products to provide critical care, and we want to reassure them that we will be with them every step of the way throughout this transition,\u201d said Valerie Asbury, General Manager of Animas Corporation. \u201cOur number one priority is ensuring patients have a seamless experience as they transition to Medtronic. For over 30 years, Medtronic has been a global leader in the treatment of those living with diabetes, and we are confident they will provide outstanding support to our patients and their healthcare teams.\u201d<\/p>\n

\u201cWe are incredibly grateful to our patients and healthcare partners for the trust, confidence and loyalty they have placed in Animas products over the last 12 years,\u201d Asbury said. \u201cWith changing needs of customers, rapidly evolving market dynamics, and increased competitive pressures, it proved too difficult to sustain the insulin pump business and we decided to pursue an exit of the business. This decision was extremely difficult and comes following the extensive exploration of all other viable options for the Animas business.\u201d<\/p>\n

Approximately 90,000 patients currently use Animas pumps and products. Those patients, caregivers and healthcare providers may explore insulin pump transition options by visiting\u00a0www.medtronicdiabetes.com\/Animas<\/a>\u00a0or contacting Medtronic at the following toll-free numbers:<\/p>\n